Exploring the mechanisms of action of FB642 at the cellular level

Journal of Cancer Research and Clinical Oncology, Supplement

Volumn 127, Issue 5, 2001, Pages 301-313

  Hammond, Lisa A ^a,b   Davidson, Karen ^a,b   Lawrence, Richard ^a,b   Camden, James B ^a,c   Von Hoff, Daniel D ^a,b   Weitman, Steve ^a,b   Izbicka, Elzbieta ^a,b  

^a CTRC Institute for Drug Development   (United States)

^b University of Texas Health Science Center   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Benzimidazoles; Methyl 2 benzimidazolecarbamate (FB642)

Indexed keywords

ANTIFUNGAL AGENT; BENZIMIDAZOLE DERIVATIVE; CARBENDAZIM; FB 642; PROTEIN P53; ANTINEOPLASTIC AGENT; CARBAMIC ACID DERIVATIVE; TUMOR PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE G2 PHASE; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; ANIMAL; BREAST TUMOR; CELL CULTURE; CELL DIVISION; COLORECTAL TUMOR; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; EXPERIMENTAL LEUKEMIA; EXPERIMENTAL MELANOMA; FEMALE; LEUKEMIA; MALE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; CANCER CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; BREAST NEOPLASMS; CARBAMATES; CELL CYCLE; CELL DIVISION; COLORECTAL NEOPLASMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENES, P53; HUMANS; LEUKEMIA; LEUKEMIA, EXPERIMENTAL; MALE; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034742670     PISSN: 09439382     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000212     Document Type: Article

References (35)

1. 1. Krechniak J, Klosowska B (1986) The fate of the 14C-carbendazim in rat. Xenobiotica 16: 809-815
2. 2. Cybulski J, Palut D (1982) Metabolism of 14C-carbendazim. Rocz Panstw Zakl Hig 33: 425-432
3. 3. Gardiner JA, Kirkland JJ, Klopping HL, Sherman H (1974) Fate of benomyl in animals. J Agric Food Chem 22: 419-427
4. 4. Hershberger LW, Arce GT (1993) Environmental health criteria for carbendazim. World Health Organization, Vammala, Finland, p 149
5. 5. Davidse LC, Flach W (1977) Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antibiotic agent in mutant strains of Aspergillus nidulans. J Cell Biol 72: 174-193
6. 6. Burland TG, Gull K (1984) Molecular and cellular aspects of the interaction of benzimidazole fungicides with tubulin and microtubules. In: Trinci APJ, Ryley JF (eds) Mode of action of antifungal agents. Cambridge University, New York, pp 300-320
7. 7. Nakai M, Hess RA (1994) Morphological changes in the rat sertoli cell induced by the microtubule poison carbendazim. Tissue Cell 26: 917-927
8. 8. Parvinen M, Kormano M (1974) Early effects of antispermatogenic benzimidazole derivatives U 32.422E and U 32.104 on the seminiferous epithelium of the rat. Andrologia 6: 245-253
9. 9. Hess RA, Moore BJ, Forrer J, Linder RE, Abuel-Atta AA (1991) The fungicide benomyl (methyl 1-(butylcarbamoyl)-2-benzimidazole carbamate) causes testicular dysfunction by inducing the sloughing of germ cells and occlusion of efferent ductules. Fundam Appl Toxicol 17: 733-745
10. 10. Tishler R, Lamppu D, Park S, Price B (1995) Microtubule-active drugs Taxol, Vinblastine, and Nocodazole increase the levels of transcriptionally active p53. Cancer Res 55: 6021-6025
11. 11. Bumbasirevic V, Skaro-Milic A, Miric A, Djuricic B (1995) Apoptosis induced by microtubule disrupting drugs in normal murine thymocytes in vitro scanning microscopy. Scanning Microsc 9: 509-518
12. 12. Inomata M, Kawashima K, Fujiwara Y, Tanaka Y, Saijo N, Kaneko A, Kunikane H (1995) Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. J Cancer Res Clin Oncol 121: 729-738
13. 13. Nagasawa Fl, Li C, Maki C, Little JB (1995) Relationship of radiation-induced G1 phase arrest and p53 function in human tumor cells. J Cell Biochem 21A: 344
14. 14. Vogelstein G (1990) A deadly inheritance. Nature 381: 681-682
15. 15. Nagasawa Fl, Li C, Maki C, Little JB (1995) Relationship of radiation-induced G1 phase arrest and p53 function in human tumor cells. J Cell Biochern 21A: 344
16. 16. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781-3784
17. 17. Michieli P, Chedid M, Lin D, Pierce JFl, Mercer WE, Givol D (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395
18. 18. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810
19. 19. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996) Uncoupling of S phase and mitosis-induced anticancer agents lacking p21. Nature 381: 713-716
20. 20. Nagasawa H, Li C, Maki C, Little JB (1995) Relationship of radiation-induced G1 phase arrest and p53 function in human tumor cells. J Cell Biochem 21A: 344
21. 21. Moore MR (1981) An insulin effect on cytoplasmic estrogen receptor in the human breast cancer cell line MCF-7. Biol Chem 256: 3637-3640
22. 22. Izbicka E, Davidson K, Yoneda T, Williams P, Von Hoff D (1996) Cytidine analogs upregulate androgen receptor expression and induce apoptosis in human prostate cancer cells in vitro. J Bone Miner Res 11: 483
23. 23. Davidson K, Koester S, Izbicka E, Von Hoff D (1996) Elimination of extrachromosomal DNA by hydroxyurea induces apoptosis in human adenocarcinoma cells COLO 320. Ann Oncol 7: 6
24. 24. Gorczyca W, Gong J, Darzynkiewic Z (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951
25. 25. Krishan A (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-195
26. 26. Cole S (1986) Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 27: 259-263
27. 27. Chomczynski P, Sacchi NG (1987) Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
28. 28. Chen D, Klebe RJ (1993) Controls for validation of relative reverse transcription PCR assays. PCR Methodol Appl 3: 127-129
29. 29. Chen D, Magnuson VL, Steffenson B, Klebe RJ (1993) Use of stock solutions to simplify mRNA quantitation by reverse transcription-PCR assays. PCR Methodol Appl 3: 351-353
30. 30. Izquierdo M, Shoemaker R, Flens M, Scheffer G, Wu L, Prather T, Scheper R (1996) Overlapping phenotypes of multidrug resistance among panels of human cancer cell lines. Int J Cancer 65: 230-237
31. 31. Schadendorf D, Makki A, Stahr C, van Dyck A, Reilmard W, Scheffer GL, Flens MJ, Schefer R, Henz B (1995) Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 147: 1545-1552
32. 32. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Nad Acad Sci 89: 7491-7495
33. 33. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
34. 34. El-Deiry W, Harper JW, O'Connor PM (1994) WAF1/CIP1 is induced in p53 mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174
35. 35. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D (1994) Induction of WAF1 /CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395